US Patent 9453076 Anti-TLR4 antibodies and uses thereof
Patent 9453076 was granted and assigned to Novimmune on September, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+180 characters)
Article
Patent abstract
Disclosed are antibodies that specifically bind Toll-like Receptor 4 (TLR-4), and to methods of using the anti-TLR4 antibodies as therapeutics and diagnostic agents.
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09453076 Anti-TLR4 antibodies and uses thereof US Patent 9453076 Anti-TLR4 antibodies and uses thereof
Infobox
Patent Number
0945307600
Patent Number
945307600
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
094530760
Date of Patent
September 27, 2016
0Patent Application Number
138531580
Date Filed
March 29, 2013
0Official Website
Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
094530760
Date of Patent
September 27, 2016
0Patent Application Number
138531580
Date Filed
March 29, 2013
0Official Website
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 8 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09453076 Anti-TLR4 antibodies and uses thereof
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09453076
Date of patent
September 27, 2016
Patent application number
13853158
Date Filed
March 29, 2013
Patent primary examiner
Find more entities like US Patent 9453076 Anti-TLR4 antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.